Screener Summaries Updates Institutions Sign In More Updates › Leadership & Pay › EW Leadership & Pay · Jul 25, 2025
Larry L. Wood will resign as Corporate Vice President and Group President of Transcatheter Aortic Valve Replacement… EW Edwards Lifesciences Corp
Larry L. Wood will resign as Corporate Vice President and Group President of Transcatheter Aortic Valve Replacement and Surgical Structural Heart, effective September 1, 2025. Daniel J. Lippis, currently Corporate Vice President for Japan, Greater China and Asia Pacific, will succeed him as Corporate Vice President responsible for Transcatheter Aortic Valve Replacement on that date.
More from Edwards Lifesciences Corp Edwards Lifesciences raises full-year sales growth guidance to approx 11.5% after Q3 revenue of $1.72B Nov 4, 2026 Edwards Lifesciences Corporation announced that Donald E. Bobo, Jr., Corporate Vice President of Strategy and… Aug 28, 2026 Edwards Lifesciences reported second quarter 2026 sales of $1.74 billion, a 13.6% increase year-over-year, with… Jul 23, 2026 Edwards Lifesciences Corporation stockholders approved an amendment to the company's Long-Term Stock Incentive… May 8, 2026 Edwards Lifesciences Corporation has appointed Theodora Mistras as Chief Financial Officer, effective May 29, 2026… May 4, 2026 All content on this site is for informational purposes only and does not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. Always consult a qualified financial advisor before making investment decisions.
Financial data is obtained from public filings and third-party providers and is provided “as-is” without any guarantee of accuracy, completeness, or timeliness.
© 2026 go-intrinsic.com. All rights reserved.
